Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Jiuxing Feng"'
Autor:
Baitong Wu, Jiuxing Feng, Jingyi Guo, Jian Wang, Guanghui Xiu, Jiaqi Xu, Ke Ning, Bin Ling, Qingchun Fu, Jun Xu
Publikováno v:
Stem Cell Research & Therapy, Vol 13, Iss 1, Pp 1-21 (2022)
Abstract Background Hepatic fibrosis is a common pathologic stage in chronic liver disease development, which might ultimately lead to liver cirrhosis. Accumulating evidence suggests that adipose-derived stromal cells (ADSCs)-based therapies show exc
Externí odkaz:
https://doaj.org/article/bed336b3bcec402991d781fc6badb5f0
Autor:
Jiuxing Feng, Shujing Chen, Shuangqi Li, Baitong Wu, Jiacheng Lu, Li Tan, Jiamin Li, Yuanlin Song, Guoming Shi, Yujiang Geno Shi, Jinjun Jiang
Publikováno v:
Translational Oncology, Vol 13, Iss 12, Pp 100865- (2020)
Monocytic myeloid-derived suppressor cells (M-MDSCs), granulocytic MDSC (G-MDSCs) and regulatory T cells (Tregs) inhibit adaptive anti-tumor immunity and undermine the efficacy of anti-PD-1 therapy. However, the impact of anti-PD-1 treatment on these
Externí odkaz:
https://doaj.org/article/ef4e04a403c84fb8a2e8b213fe611712
Autor:
Irfete S. Fetahu, Guo-Ming Shi, Yujiang Geno Shi, Xin-Yu Zhang, Jia-Bin Cai, Dingailu Ma, Hang Liu, Isabella Iwanicki, Feizhen Wu, Bingjie Wang, Tao Hu, Jiuxing Feng, Li Tan, Shuangqi Li, Haikun Wang
Publikováno v:
EMBO reports. 21
The host immune response is a fundamental mechanism for attenuating cancer progression. Here we report a role for the DNA demethylase and tumor suppressor TET2 in host anti-tumor immunity. Deletion of Tet2 in mice elevates IL-6 levels upon tumor chal
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::ebb8b97856ef1b9e045a6f6f28b2d92e
https://doi.org/10.15252/embr.201949425
https://doi.org/10.15252/embr.201949425
Autor:
Baitong Wu, Jiuxing Feng, Jiamin Li, Guo-Ming Shi, Yujiang Geno Shi, Jia-Cheng Lu, Li Tan, Shuangqi Li, Shujing Chen, Yuanlin Song, Jinjun Jiang
Publikováno v:
Translational Oncology
Translational Oncology, Vol 13, Iss 12, Pp 100865-(2020)
Translational Oncology, Vol 13, Iss 12, Pp 100865-(2020)
Monocytic myeloid-derived suppressor cells (M-MDSCs), granulocytic MDSC (G-MDSCs) and regulatory T cells (Tregs) inhibit adaptive anti-tumor immunity and undermine the efficacy of anti-PD-1 therapy. However, the impact of anti-PD-1 treatment on these
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::942c3771854d191ffc48d31e9cf97daa
https://doi.org/10.1016/j.tranon.2020.100865
https://doi.org/10.1016/j.tranon.2020.100865